BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
Mechanistic comparison of lobelia chinensis and paeonia suffruticosa based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
lobelia and paeonia share 4463 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.662 means 66% of the combined target set is bound by both compounds. The IDF-weighted score of 0.637 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do lobelia and paeonia have in common?
lobelia and paeonia share 4463 molecular targets with a Jaccard similarity of 66%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can lobelia and paeonia be combined?
lobelia and paeonia share 4463 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: lobelia or paeonia?
In the BiohacksAI corpus: lobelia has 38 PubMed-indexed studies, paeonia has 199 studies.